Ifp Advisors, Inc Bio Affinity Technologies, Inc. Transaction History

Ifp Advisors, Inc

$3.59 Billion
Q3 2025

A detailed history of Ifp Advisors, Inc transactions in Bio Affinity Technologies, Inc. stock. As of the latest transaction made, Ifp Advisors, Inc holds 25,000 shares of BIAF stock, worth $46,000. This represents 0.0% of its overall portfolio holdings.

Number of Shares

25,000

Previous 25,000 -0.0%

Holding current value

$46,000

Previous $7,000 957.14%

% of portfolio

0.0%

Previous 0.0%

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Jul 24, 2025	BUY	$0.2 - $1.09 $2,000 - $10,900	10,000 Added 66.67%	25,000 $7,000
Q1 2025 May 05, 2025	BUY	$0.26 - $0.97 $1,300 - $4,850	5,000 Added 50.0%	15,000 $3,000
Q2 2024 Jul 30, 2024	BUY	$1.76 - $3.0 $8,800 - $15,000	5,000 Added 100.0%	10,000 $21,000
Q4 2023 Jan 09, 2024	BUY	$1.18 - $1.69 $5,900 - $8,450	5,000 New	5,000 $7,000

Others Institutions Holding BIAF

# of Institutions

Shares Held

78.7K

Call Options Held

Put Options Held

View Full List

About bioAffinity Technologies, Inc.

Ticker BIAF
Exchange
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 2,727,580
Market Cap $5.02M
Description
bioAffinity Technologies, Inc., a biotechnology company, engages in developing non-invasive diagnostic tests and targeted cancer therapeutics. The company offers CyPath lung, a diagnostic test, for early detection of lung cancer. It also researches targeted therapies to treat cancer at the cellular level. The company was founded in 2014 and is b...

More about BIAF

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ifp Advisors, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ifp Advisors, Inc with notifications on news.

Account